NYSE:RERE • US00138L1089
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ATRENEW INC (RERE).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-07-15 | B of A Securities | Initiate | Buy |
| 2021-07-14 | Goldman Sachs | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.869B 26.85% | 12.966B 31.37% | 16.328B 25.93% | 21.352B 30.77% | 26.692B 25.01% | 32.811B 22.92% | |
| EBITDA YoY % growth | -398.3M 23.61% | 161M 140.42% | 296M 83.85% | 529.59M 78.92% | 821.72M 55.16% | 1.098B 33.62% | |
| EBIT YoY % growth | -803.7M 10.21% | -173M 78.47% | 29M 116.76% | 536.01M 1,748.31% | 806.34M 50.43% | 1.149B 42.50% | |
| Operating Margin | -8.14% | -1.33% | 0.18% | 2.51% | 3.02% | 3.50% | |
| EPS YoY % growth | N/A 65.85% | N/A 172.64% | N/A -76.62% | 1.16 929.29% | 2.02 6.69% | 4.06 101.35% |
All data in CNY
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CNY
8 analysts have analysed RERE and the average price target is 7.57 USD. This implies a price increase of 34.64% is expected in the next year compared to the current price of 5.6187.